Phase 1 Advanced Solid Tumor Cancer Clinical Trials
6 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–6 of 6 trials
Recruiting
Phase 1Phase 2
Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors
Advanced Solid Tumor Cancer
BioNTech SE533 enrolled4 locationsNCT07455734
Recruiting
Phase 1
A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced Solid Tumors
Advanced Solid Tumor Cancer
HC Biopharma Inc.331 enrolled1 locationNCT07477743
Recruiting
Phase 1
X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma
Advanced Solid Tumor Cancer
Immunolight, LLC52 enrolled4 locationsNCT04389281
Recruiting
Phase 1
A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer
Advanced Solid Tumor Cancer
HC Biopharma Inc.328 enrolled1 locationNCT07381829
Recruiting
Phase 1
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Advanced Solid Tumor Cancer
Calico Life Sciences LLC248 enrolled30 locationsNCT04777994
Recruiting
Phase 1
Phase I Clinical Study of YK1101 Injection for the Treatment of Advanced Solid Tumors
Advanced Solid Tumor Cancer
Peking University10 enrolled2 locationsNCT07139067